Title: The Study of in Vitro Sensitivity and Resistance Pattern of Antibiotics in Neonatal Septicemia in Tertiary Care Hospital

Authors: Dr Shruti Dhale, Dr Subhash Valinjkar, Dr Sapna Anjutagi, Dr Vighnesh Narkhede

 DOI:  http://dx.doi.org/10.18535/jmscr/v4i8.07

Abstract

Aims and objectives

1.      To study in vitro sensitivity and resistance pattern of antibiotics in neonatal septicemia.

2.      To find out the incidence of blood culture positive neonatal septicemia in tertiary care hospital

Study Design: This was a Prospective observational cohort study which was conducted in a tertiary care center in a metropolitan city.

Materials and methods: All symptomatic neonates upto 28 days old admitted in NICU of our institute with history and clinical symptoms suggestive of neonatal septicemia were enrolled in this study. The blood culture of all the suspected cases having clinical signs and symptoms of neonatal septicemia were analyzed and studied for culture sensitivity and resistance pattern. Incidence of blood culture positive neonatal septicemia amongst all neonates admitted in neonatal intensive care unit over the study period was aldo calculated.

Results: Over the study period a total of 2035 neonates were admitted in our NICU. Out of these 2035 Neonates 197 neonates were diagnosed to be having sepsis depending upon clinical criteria. All these 197 cases were studied in this study. Blood samples were drawn from all these neoates and CBC,CRP and blood culture tests were done.  On clinical examination the most common signs in these children were Retraction, Flaring, grunting (36.55%), oliguria (26.4%), lethargy (27.41%), vomiting (19.29%) and poor feeding (17.26%). High pitched cry, hyporeflexia, petechial, purpura and hypotonia were least common signs which were seen in 0.51 % cases. Irregular respiration and splenomegaly was not seen in any patient. Blood culture was positive in 53 cases. Out of these 53 blood culture positive cases 28 (52.8%)   cases were having lateonset sepsisand 25 (47.2%) caseswere having early onset sepsis. An analysis of culture and sensitivity pattern of the blood culture positive cases revealed that overall most common organisms involved in cases of neonatal sepsis were  methicillin-susceptible coagulase-negative staphylococci [MSCoNS] (22.64%) followed by enterobacter (16.98%), Methicillin-resistant staphylococcus aureus (13.2%) and klebsiella pneumonia (13.2%) . The most common gram positive organisms involved in neonatal sepsis were MSCoNS (22.64%) while the gram negative organisms most commonly involved were enterobacter (16.98%). 3(5.66%) had fungal septicemia caused by candida.  Patients The least common organisms involved in neonatal sepsis were found to be due to E.tarda, C.Frundi and of polymicrobial etiology which was seen in 1.88% cases each.  The study of sensitivity pattern of organisms revealed that 100% of MRSA were susceptible to ciprofloxacin, ofloxacin, amikacin and gentamicin. E-coli was sensitive to ciprofloxacin, meropenam and amikacin. Klebsiella isolated were found to be relatively resistant to ofloxacin and imipenem while acitenobacter were found to be susceptible to colistin in only 60% cases.

Conclusion: Neonatal sepsis is one of the major cause of morbidity and mortality. Its incidence is increasing as more premature and low birth weight babies are resuscitated and are being managed in neonatal intensive care units. Prematurity, low birth weight babies and male gender are associated with increased risk of developing sepsis. In view of the changing spectrum of the causative agents of neonatal septicemia and their antibiotic sensitivity and resistance patterns from time to time and from one hospital to another, a positive blood culture and the antibiotic sensitivity and resistance pattern testing of the isolates are the best guide to the antimicrobial therapy and which would be beneficial for the best outcome of the disease. Early diagnosis and prompt antibiotic therapy is the key to management of neonatal sepsis.

Keywords: neonatal sepsis, Early onset Sepsis, Late onset sepsis, Blood culture and sensitivity, Antibiotic theapy.

References

 

1.      Vergnano S, Sharland M, Kazembe P, Mwansambo C, Heath P. Neonatal sepsis: an international perspective. Archives of Disease in Childhood Fetal and Neonatal Edition. 2005;90(3):F220-F224. doi:10.1136/adc.2002.022863.

2.      Shah AJ, Mulla SA, Revdiwala SB. Neonatal Sepsis: High Antibiotic Resistance of the Bacterial Pathogens in a Neonatal Intensive Care Unit of a Tertiary Care Hospital. Journal of Clinical Neonatology. 2012;1(2):72-75. doi:10.4103/2249-4847.96753.

3.      Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK Jr, Smith PB, Manzoni P, Jacqz-Aigrain E, Kaguelidou F, Cohen-Wolkowiez M. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012 May;88Suppl 2:S69-74.

4.      Stoll BJ, Hansen NI, Sánchez PJ, et al. Early Onset Neonatal Sepsis: The Burden of Group B Streptococcal and E. coli  Disease Continues. Pediatrics. 2011;127 (5):817-826.

5.      Brito DV, von Dolinger EJ, Abdallah VO, Darini AL, GontijoFilho PP. Two outbreaks of mixed etiology associated with central venous catheters inserted by  phlebotomy in critical neonates. Braz J Infect Dis. 2009 Jun;13(3):177-82

6.      Mathur NB, Agarwal HS, Maria A. Acute renal failure in neonatal sepsis. Indian J Pediatr. 2006 Jun;73(6):499-502.

7.      Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to the diagnosis of early onset neonatal sepsis. Archives of Disease in Childhood Fetal and Neonatal Edition. 2006; 91(3):F208-F212.

8.      Du Pont-Thibodeau G, Joyal J-S, Lacroix J. Management of neonatal sepsis in term newborns. F1000Prime Reports. 2014; 6:67. doi:10.12703/P6-67.

9.      Klinger G, Levy I, Sirota L, et al. Epidemiology and risk factors for early onset sepsis among very-low-birthweight infants. Am J Obstet Gynecol. 2009 Jul. 201(1):38.e1-6. [Medline].

10.  van den Hoogen A, Gerards LJ, Verboon-Maciolek MA, Fleer A, Krediet TG. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology. 2010. 97(1):22-8. [Medline].

11.  Lin FY, Weisman LE, Azimi P, et al. Assessment of Intrapartum Antibiotic Prophylaxis for the Prevention of Early-onset Group B Streptococcal Disease. Pediatr Infect Dis J. 2011 Sep. 30(9):759-763.

12.  Wynn JL, Wong HR. Pathophysiology and Treatment of Septic Shock in Neonates. Clinics in perinatology. 2010;37(2):439-479. doi:10.1016/j.clp.2010.04.002.

13.  Shah BA, Padbury JF. Neonatal sepsis: An old problem with new insights. Virulence. 2014;5(1):170-178. doi:10.4161/viru.26906.

14.  Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal Infectious Diseases: Evaluation of Neonatal Sepsis. Pediatric clinics of North America. 2013;60(2):367-389.

15.  Daniels JP, Gray J, Pattison HM, Gray R, Hills RK, Khan KS, Intrapartum tests for group B streptococcus: accuracy and acceptability of screening. GBS Collaborative GroupBJOG. 2011 Jan; 118(2):257-65.

16.  Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Committee on Infectious Diseases, Committee on Fetus and Newborn, Baker CJ, Byington CL, Polin RA Pediatrics. 2011 Sep; 128(3):611-6.

17.  Schrag S, Schuchat A. Prevention of neonatal sepsis. ClinPerinatol. 2005 Sep;32(3):601-15. Review. PubMed PMID: 16085022.

18.  Wang WH, Xu D, Han YM, Yang ZJ. [Risk factors for early disseminated intravascular coagulation in neonates with sepsis]. Zhongguo Dang Dai ErKeZaZhi. 2015 Apr;17(4):341-4.

19.  Kali A, Sivaraman U, Sreenivasan S, Stephen S. Neonatal sepsis and multiple skin abscess in a newborn with Down’s syndrome: A case report. The Australasian Medical Journal. 2013;6(2):91-93.

20.  Mancuso G, Cusumano V, Genovese F, Gambuzza M, Beninati C, Teti G. Role of interleukin 12 in experimental neonatal sepsis caused by group B streptococci. Infection and Immunity. 1997;65(9):3731-3735.

Corresponding Author

Dr Vighnesh Narkhede

Pediatric Resident, Department of Pediatrics, CWC Building,

GGMC & J. J. Hospital, Byculla, Mumbai-08